Predictive renal safety biomarkers and biomarker signatures to monitor kidney function

Details for Australian Patent Application No. 2008231738 (hide)

Owner Novartis AG

Inventors Roth, Daniel Robert; Vonderscher, Jacky; Dieterle, Frank; Cordier, Andre; Grenet, Olivier; Stadtler, Frank; Mahl, Andreas; Perentes, Elias; Wahl, Daniel; Maurer, Gerard

Agent Davies Collison Cave

Pub. Number AU-B-2008231738

PCT Pub. Number WO2008/116867

Priority 60/908,094 26.03.07 US

Filing date 25 March 2008

Wipo publication date 2 October 2008

Acceptance publication date 27 September 2012

International Classifications

C07K 16/30 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

G01N 33/50 Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 33/68 Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

15 October 2009 PCT application entered the National Phase

  PCT publication WO2008/116867 Priority application(s): WO2008/116867

27 September 2012 Application Accepted

  Published as AU-B-2008231738

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008231744-Oral contraceptive regimen

2008231735-Method for reducing the mercury content of natural gas condensate and natural gas processing plant